Granulocyte macrophage colonystimulating factor as a predictor of the response of metastatic renal cell carcinoma to tyrosine kinase inhibitor therapy

By                        

Molecular and Clinical Oncology, Vol. 2, Iss. 6, 2014-01 ,pp. : 1023-1027

Spandidos Publications

Access to resources Recommend Favorite

HR23b expression is a potential predictive biomarker for HDAC inhibitor treatment in mesenchymal tumours and is associated with response to vorinostat

By  

The Journal Of Pathology: Clinical Research, Vol. 2, Iss. 2, 2016-04 ,pp. : 59-71

John Wiley & Sons Inc

Access to resources Recommend Favorite

Inhibition of obliterative bronchiolitis by platelet-derived growth factor receptor protein-tyrosine kinase inhibitor

By Kallio E.   Koskinen P.   Buchdunger E.   Lemstrom K.  

Transplantation Proceedings, Vol. 31, Iss. 1, 1999-02 ,pp. : 187-187

Elsevier

Access to resources Recommend Favorite

Prevention of cardiac allograft arteriosclerosis by protein-tyrosine kinase inhibitor selective for platelet-derived growth factor receptor

By Koskinen P.   Sihvola R.   Myllarniemi M.   Hayry P.   Buchdunger E.   Lemstrom K.  

Transplantation Proceedings, Vol. 31, Iss. 1, 1999-02 ,pp. : 102-102

Elsevier

Access to resources Recommend Favorite

Localized gastrointestinal stromal tumor of the rectum: An uncommon primary site with prominent disease and treatment-related morbidities

By Farid  

Molecular and Clinical Oncology, Vol. 1, Iss. 1, 2013-01 ,pp. : 190-194

Spandidos Publications

Access to resources Recommend Favorite